The resulting weight lost benefits over 400 medical risks and conditions
The most popular study on Wegovy for obesity is the STEP 1 Trial, a large randomized control trial with about 1900 participants that examined how effective Wegovy (semaglutide) was at treating obesity in non-diabetic patients (3)
At UT Southwestern, Ob/Gyns, maternal-fetal medicine doctors, endocrinologists, and obesity specialists in the Weight Wellness Program can help you understand what body composition is healthy for you, treat underlying emotional and physical factors associated with subfertility and obesity, and explore weight management options such as lifestyle changes, bariatric surgery, and medication that is approved for use during pregnancy
Yes, you can expect to lose 1-5 lbs of weight in the first 1-2 weeks of semaglutide use
Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study